The chief executive of Altria Group Inc. is turning up ... in hopes of getting the attention of the Trump administration’s version of the Food and Drug Administration. Billy Gifford told ...

While smokable product sales are declining slowly, sales of non-smokable products are driving growth for Altria Group. The ...

Despite regulatory efforts, unauthorized disposable vapes continue to dominate a significant portion of the U.S. e-cigarette ...

Sales of unauthorised, flavoured disposable vapes in the United States amounted to around $2.4 billion in 2024, or 35% of the ...

ALTRIA PRESENTS AS PART OF THE CONSUMER ANALYST GROUP OF NEW YORK CONFERENCE; REAFFIRMS 2025 FULL-YEAR EARNINGS GUIDANCE ...

The race is on for success in harm reduction: encouraging smokers to switch completely to reduced risk alternatives. Evidence ...

Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...

LONDON (Reuters) - British American Tobacco is optimistic U.S. President Donald Trump's new administration can tackle a vast market for illegal vapes in the United States, Chief Executive Tadeu ...

Marshall claims that lobbyist Mark Baker, acting on behalf of Altria and NJOY ... so that only vaping products endorsed by the Food and Drug Administration could be sold in Montana.

By Christina Jewett Reporting from Washington Jim Jones, the director of the Food and Drug Administration’s food division, resigned on Monday, citing what he called “indiscriminate” layoffs ...

Altria Group's dividend keeps climbing ... three e-cigarette brands authorized for sale in the U.S. by the Food and Drug Administration (FDA). Fourth-quarter NJOY consumables shipped grew 15.3 ...